151 related articles for article (PubMed ID: 14978080)
1. Transgenic expression of insulin receptor substrate 2 in murine B cells alters the cell density-dependence of IgE production in vitro and enhances IgE production in vivo.
Kelly-Welch AE; Wang HY; Wang LM; Pierce JH; Jay G; Finkelman F; Keegan AD
J Immunol; 2004 Mar; 172(5):2803-10. PubMed ID: 14978080
[TBL] [Abstract][Full Text] [Related]
2. Expression of a constitutively active Stat6 in vivo alters lymphocyte homeostasis with distinct effects in T and B cells.
Bruns HA; Schindler U; Kaplan MH
J Immunol; 2003 Apr; 170(7):3478-87. PubMed ID: 12646608
[TBL] [Abstract][Full Text] [Related]
3. A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis by mutagenesis.
Wang HY; Zamorano J; Keegan AD
J Biol Chem; 1998 Apr; 273(16):9898-905. PubMed ID: 9545332
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function.
Hoshino T; Kawase Y; Okamoto M; Yokota K; Yoshino K; Yamamura K; Miyazaki J; Young HA; Oizumi K
J Immunol; 2001 Jun; 166(12):7014-8. PubMed ID: 11390444
[TBL] [Abstract][Full Text] [Related]
5. Costimulation of resting B lymphocytes alters the IL-4-activated IRS2 signaling pathway in a STAT6 independent manner: implications for cell survival and proliferation.
Zamorano J; Kelly AE; Austrian J; Wang HY; Keegan AD
Cell Res; 2001 Mar; 11(1):44-54. PubMed ID: 11305324
[TBL] [Abstract][Full Text] [Related]
6. Suppression of IgE responses in CD23-transgenic animals is due to expression of CD23 on nonlymphoid cells.
Payet-Jamroz M; Helm SL; Wu J; Kilmon M; Fakher M; Basalp A; Tew JG; Szakal AK; Noben-Trauth N; Conrad DH
J Immunol; 2001 Apr; 166(8):4863-9. PubMed ID: 11290762
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of the B cell receptor, CD86 (B7-2), and the beta 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell.
Kasprowicz DJ; Kohm AP; Berton MT; Chruscinski AJ; Sharpe A; Sanders VM
J Immunol; 2000 Jul; 165(2):680-90. PubMed ID: 10878340
[TBL] [Abstract][Full Text] [Related]
8. NF-kappa B activation plays an important role in the IL-4-induced protection from apoptosis.
Zamorano J; Mora AL; Boothby M; Keegan AD
Int Immunol; 2001 Dec; 13(12):1479-87. PubMed ID: 11717189
[TBL] [Abstract][Full Text] [Related]
9. Dextran-conjugated anti-IgD antibodies inhibit T cell-mediated IgE production but augment the synthesis of IgM and IgG.
Peçanha LM; Yamaguchi H; Lees A; Noelle RJ; Mond JJ; Snapper CM
J Immunol; 1993 Mar; 150(6):2160-8. PubMed ID: 7680684
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of IgG1 and IgE production by stimulation of the B cell CTLA-4 receptor.
Pioli C; Gatta L; Ubaldi V; Doria G
J Immunol; 2000 Nov; 165(10):5530-6. PubMed ID: 11067906
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of insulin receptor substrate-1, but not insulin receptor substrate-2, protects a T cell hybridoma from activation-induced cell death.
Li L; Qi X; Williams M; Shi Y; Keegan AD
J Immunol; 2002 Jun; 168(12):6215-23. PubMed ID: 12055235
[TBL] [Abstract][Full Text] [Related]
12. B cell activation and Ig, especially IgE, production is inhibited by high CD23 levels in vivo and in vitro.
Cho SW; Kilmon MA; Studer EJ; van der Putten H; Conrad DH
Cell Immunol; 1997 Aug; 180(1):36-46. PubMed ID: 9316637
[TBL] [Abstract][Full Text] [Related]
13. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
Stütz AM; Woisetschläger M
J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
[TBL] [Abstract][Full Text] [Related]
14. STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination.
Linehan LA; Warren WD; Thompson PA; Grusby MJ; Berton MT
J Immunol; 1998 Jul; 161(1):302-10. PubMed ID: 9647237
[TBL] [Abstract][Full Text] [Related]
15. Dok-1 is a positive regulator of IL-4 signalling and IgE response.
Inoue A; Yasuda T; Yamamoto T; Yamanashi Y
J Biochem; 2007 Aug; 142(2):257-63. PubMed ID: 17827176
[TBL] [Abstract][Full Text] [Related]
16. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo.
Sato TA; Widmer MB; Finkelman FD; Madani H; Jacobs CA; Grabstein KH; Maliszewski CR
J Immunol; 1993 Apr; 150(7):2717-23. PubMed ID: 8454851
[TBL] [Abstract][Full Text] [Related]
17. STAT6 is required for the regulation of IL-4-induced cytoskeletal events in B cells.
Davey EJ; Greicius G; Thyberg J; Severinson E
Int Immunol; 2000 Jul; 12(7):995-1003. PubMed ID: 10882411
[TBL] [Abstract][Full Text] [Related]
18. In vivo IL-4 responses to anti-IgD antibody are MHC class II dependent and beta 2-microglobulin independent and develop normally in the absence of IL-4 priming of T cells.
Morris SC; Coffman RL; Finkelman FD
J Immunol; 1998 Apr; 160(7):3299-304. PubMed ID: 9531287
[TBL] [Abstract][Full Text] [Related]
19. STAT6, NF-kappaB and C/EBP in CD23 expression and IgE production.
Tinnell SB; Jacobs-Helber SM; Sterneck E; Sawyer ST; Conrad DH
Int Immunol; 1998 Oct; 10(10):1529-38. PubMed ID: 9796920
[TBL] [Abstract][Full Text] [Related]
20. ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling.
Watanabe M; Watanabe S; Hara Y; Harada Y; Kubo M; Tanabe K; Toma H; Abe R
J Immunol; 2005 Feb; 174(4):1989-96. PubMed ID: 15699127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
